Janos Radó comment on the 2017 research article of Lin, Zhang, Feng et al., "Aliskiren increases aquaporin-2 expression and attenuates lithium-induced nephrogenic diabetes insipidus" 

Janos Radó’s reply to Samuel Gershon’s comment

        Thank you for your remarks.  I agree with you completely. There is still a need for adequate clinical validation as to which, if any, is the most effective available therapy and how it should be employed.

        I appreciate your interest and useful comments on our work.

December 23, 2021